has been recapitalized by
ABOUT THE COMPANY:
SDS Rx (“SDS”), a provider of healthcare delivery services, specializes in the movement of pharmaceuticals from wholesale distributors to pharmacies, as well as from long-term care (“LTC”) pharmacies to LTC facilities. SDS leverages an asset-light model and executes its deliveries through a network of independent contractors. The Company enjoyed strong historical growth through its value-added operational model and its focus on pharmaceutical products.
SITUATION:
The SDS management team was seeking a value-add partner to help recapitalize the business and execute its clear growth strategy.
ENGAGEMENT:
G2 was engaged to analyze and advise on potential strategic alternatives, as well as to identify and pursue potential growth opportunities – including sourcing capital from the traditional debt lending and private equity markets. Management ultimately selected a majority recapitalization and called on G2 to run a high-touch process to successfully execute the transaction.
OUTCOME:
The transaction was successfully executed in May 2018 through a recapitalization with HCI Equity Partners.
MORE LIKE THIS
Exclusive Sell-Side Advisor
has been sold to a Global Leader in the Construction, Infrastructure and Energy Markets
Exclusive Sell-Side Advisor
Flash Global, a portfolio company of PineBridge Investments and Graycliff Partners has been sold to Comvest Partners
Exclusive Sell-Side Advisor
Kaiser Consulting has been acquired by Pine Tree Equity Partners
Exclusive Sell-Side Advisor
a leading provider of packaging solutions has been acquired by Berlin Packaging
Exclusive Sell-Side Advisor
a portfolio company of Sopris Capital has been acquired by InhabitIQ
Connect With Us.
